California Should Expect Modest Royalties From Stem Cell Firms
The California stem cell agency is going to give folks a glimpse later this month at its initial thinking concerning the division of spoils from inventions that come about from its grants to commercial firms.
But we already have a suggestion from one interested party that the state's share be modest. Fred Middleton, managing director of a biomedical ven…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.